Overview

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions

Status:
Completed

Trial end date:
2005-06-01

Target enrollment:

Participant gender:

Summary

An open label, randomized, single-center, single-dose, two-treatment, two-period, crossover bioavailability study comparing Cetirizine Hydrochloride 10 mg tablet of Ohm Laboratories Inc. (A subsidiary of Ranbaxy, Inc) with Zyrtec® Cetirizine Hydrochloride, 10 mg tablet of Pfizer Labs (Division of Pfizer Inc.) in healthy, adult, human subjects under fed condition

Phase:

N/A

Details

Lead Sponsor:

Ranbaxy Laboratories Limited

Collaborator:

Ohm Laboratories, Inc.

Treatments:

Cetirizine